BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 28990111)

  • 1. MicroRNA‑720 inhibits pancreatic cancer cell proliferation and invasion by directly targeting cyclin D1.
    Zhang Y; Su Y; Zhao Y; Lv G; Luo Y
    Mol Med Rep; 2017 Dec; 16(6):9256-9262. PubMed ID: 28990111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of miR-34a contributes to the proliferation and migration of laryngeal carcinoma cells by targeting cyclin D1.
    Ye J; Li L; Feng P; Wan J; Li J
    Oncol Rep; 2016 Jul; 36(1):390-8. PubMed ID: 27220728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA‑584 directly targets CCND1 and inhibits cell proliferation and invasion in pancreatic cancer.
    Chen G; Hu M; Qu X; Wang K; Qu Y
    Mol Med Rep; 2019 Jan; 19(1):719-726. PubMed ID: 30431107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-503 suppresses proliferation and cell-cycle progression of endometrioid endometrial cancer by negatively regulating cyclin D1.
    Xu YY; Wu HJ; Ma HD; Xu LP; Huo Y; Yin LR
    FEBS J; 2013 Aug; 280(16):3768-79. PubMed ID: 23731275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetically altered miR-193b targets cyclin D1 in prostate cancer.
    Kaukoniemi KM; Rauhala HE; Scaravilli M; Latonen L; Annala M; Vessella RL; Nykter M; Tammela TL; Visakorpi T
    Cancer Med; 2015 Sep; 4(9):1417-25. PubMed ID: 26129688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-193b inhibits the proliferation, migration and invasion of gastric cancer cells via targeting cyclin D1.
    Wang L; Zhang Y; Zhao L; Liu S; Yu S; Ma Y; Sun G
    Acta Histochem; 2016 May; 118(4):323-30. PubMed ID: 27071318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-195 inhibits the proliferation of human cervical cancer cells by directly targeting cyclin D1.
    Li Z; Wang H; Wang Z; Cai H
    Tumour Biol; 2016 May; 37(5):6457-63. PubMed ID: 26631043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-193a-5p and -3p Play a Distinct Role in Gastric Cancer: miR-193a-3p Suppresses Gastric Cancer Cell Growth by Targeting ETS1 and CCND1.
    Chou NH; Lo YH; Wang KC; Kang CH; Tsai CY; Tsai KW
    Anticancer Res; 2018 Jun; 38(6):3309-3318. PubMed ID: 29848678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-196a promotes pancreatic cancer progression by targeting nuclear factor kappa-B-inhibitor alpha.
    Huang F; Tang J; Zhuang X; Zhuang Y; Cheng W; Chen W; Yao H; Zhang S
    PLoS One; 2014; 9(2):e87897. PubMed ID: 24504166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-101 inhibits cell proliferation and invasion of pancreatic cancer through targeting STMN1.
    Zhu L; Chen Y; Nie K; Xiao Y; Yu H
    Cancer Biomark; 2018; 23(2):301-309. PubMed ID: 30198871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-377 inhibits the proliferation of pancreatic cancer by targeting Pim-3.
    Chang W; Liu M; Xu J; Fu H; Zhou B; Yuan T; Chen P
    Tumour Biol; 2016 Nov; 37(11):14813-14824. PubMed ID: 27638830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-215 functions as a tumor suppressor and directly targets ZEB2 in human pancreatic cancer.
    Li QW; Zhou T; Wang F; Jiang M; Liu CB; Zhang KR; Zhou Q; Tian Z; Hu KW
    Genet Mol Res; 2015 Dec; 14(4):16133-45. PubMed ID: 26662405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor suppressor role of microRNA-1296 in triple-negative breast cancer.
    Phan B; Majid S; Ursu S; de Semir D; Nosrati M; Bezrookove V; Kashani-Sabet M; Dar AA
    Oncotarget; 2016 Apr; 7(15):19519-30. PubMed ID: 26799586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-146a-5p inhibits cell proliferation and cell cycle progression in NSCLC cell lines by targeting CCND1 and CCND2.
    Li YL; Wang J; Zhang CY; Shen YQ; Wang HM; Ding L; Gu YC; Lou JT; Zhao XT; Ma ZL; Jin YX
    Oncotarget; 2016 Sep; 7(37):59287-59298. PubMed ID: 27494902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA‑628‑5p inhibits cell proliferation and induces apoptosis in colorectal cancer through downregulating CCND1 expression levels.
    Guo F; Xue J
    Mol Med Rep; 2020 Mar; 21(3):1481-1490. PubMed ID: 32016467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-133a functions as a tumor suppressor and directly targets FSCN1 in pancreatic cancer.
    Qin Y; Dang X; Li W; Ma Q
    Oncol Res; 2013; 21(6):353-63. PubMed ID: 25198665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-15a and miR-16-1 downregulate CCND1 and induce apoptosis and cell cycle arrest in osteosarcoma.
    Cai CK; Zhao GY; Tian LY; Liu L; Yan K; Ma YL; Ji ZW; Li XX; Han K; Gao J; Qiu XC; Fan QY; Yang TT; Ma BA
    Oncol Rep; 2012 Nov; 28(5):1764-70. PubMed ID: 22922827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA‑296 targets AKT2 in pancreatic cancer and functions as a potential tumor suppressor.
    Li H; Li J; Shi B; Chen F
    Mol Med Rep; 2017 Jul; 16(1):466-472. PubMed ID: 28534950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homeobox gene CDX2 inhibits human pancreatic cancer cell proliferation by down-regulating cyclin D1 transcriptional activity.
    Takahashi K; Hirano F; Matsumoto K; Aso K; Haneda M
    Pancreas; 2009 Jan; 38(1):49-57. PubMed ID: 19106744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-545 inhibited pancreatic ductal adenocarcinoma growth by targeting RIG-I.
    Song B; Ji W; Guo S; Liu A; Jing W; Shao C; Li G; Jin G
    FEBS Lett; 2014 Nov; 588(23):4375-81. PubMed ID: 25315416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.